Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intraperitoneal chemotherapy (IPC) in older women with epithelial ovarian cancer (EOC)
    Meeting Abstract

    Tew, W. P.; O'Cearbhaill, R.; Zhou, Q.; Thaler, H.; Konner, J.; Hensley, M. L.; Sabbatini, P.; Spriggs, D.; Aghajanian, C.; Lichtman, S. M.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Evaluation of the role of aromatase inhibitors (AIs) in the treatment of uterine leiomyosarcoma (uLMS)
    Meeting Abstract

    O'Cearbhaill, R.; Zhou, Q.; Iasonos, A.; Soslow, R. A.; Leitao, M. M. Jr; Aghajanian, C. A.; Hensley, M. L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • First-in-human phase I study of the novel structure proteasome inhibitor NPI-0052
    Meeting Abstract

    Hamlin, P. A.; Aghajanian, C.; Younes, A.; Hong, D. S.; Palladino, M. A.; Longenecker, A. M.; Lloyd, G. K.; Hannah, A. L.; Spear, M. A.; Kurzrock, R.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant epithelial ovarian cancer (PR-EOC): A CTEP-sponsored phase II study
    Meeting Abstract

    Hensley, M. L.; Kravetz, S.; Sima, C.; Tew, W.; Pereira, L.; Sabbatini, P.; Whalen, C.; Aghajanian, C. A.; Zarwan, C.; Berlin, S.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II evaluation of bevacizumab in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group (GOG) study
    Meeting Abstract

    Aghajanian, C.; Sill, M. W.; Darcy, K.; Greer, B.; McMeekin, D. S.; Rose, P. G.; Rotmensch, J.; Barnes, M. N.; Hanjani, P.; Leslie, K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Incidence and management of bevacizumab-associated gastrointestinal perforation in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Diaz, J. P.; Zivanovic, O.; Tew, W. P.; Konner, J.; Sabbatini, P. J.; Chi, D. S.; Aghajanian, C.; Barakat, R. R.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy
    Journal Article

    Zivanovic, O.; Leitao, M. M. Jr; Park, K. J.; Zhao, H.; Diaz, J. P.; Konner, J.; Alektiar, K.; Chi, D. S.; Abu-Rustum, N. R.; Aghajanian, C.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Journal Article

    Schilder, R. J.; Pathak, H. B.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Aghajanian, C.; Min, H.; Devarajan, K.; Ross, E.; Drescher, C. W.; more...
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: Morphologic and immunohistochemical features to resolve a diagnostic dilemma
    Journal Article

    Lewin, S. N.; Aghajanian, C.; Moreira, A. L.; Soslow, R. A.
    American Journal of Surgical Pathology (2009)

    Fulltext@MSK | Save